Teva scrambles to match 30% Copaxone discounts from Mylan's knockoff: analyst

9th October 2017 Uncategorised 0

Just how much Mylan’s generic of 40-mg multiple sclerosis blockbuster Copaxone ends up hurting Teva depends on the knockoff’s pricing, and on Monday one analyst offered a window into how things are playing out so far.

More: Teva scrambles to match 30% Copaxone discounts from Mylan's knockoff: analyst
Source: fierce